Mangiagli A, Campisi S, Piazza L, Lo Monaco D
Servizio per la Prevenzione e la Cura delle Talassemie, P.O. Umberto I, Siracusa, Italia.
Pediatr Med Chir. 1995 Mar-Apr;17(2):151-2.
The aim of this study is to evaluate the prevalence of the HCV antibodies in the relatives of polytransfused patients with different haemoglobinopathies. Our results have shown that 4.7% of relatives are aHCV positive. This incidence is much higher than that one reported in scientific publications with regard to non-haemoglobinopathis aHCV positive patients. Therefore a careful prevention and surveillance is needed in order to avoid the risk of infection in these subjects.
本研究的目的是评估不同血红蛋白病多次输血患者亲属中丙型肝炎病毒（HCV）抗体的流行情况。我们的结果显示，4.7%的亲属抗-HCV呈阳性。这一发生率远高于科学出版物中报道的非血红蛋白病抗-HCV阳性患者的发生率。因此，需要进行仔细的预防和监测，以避免这些人群感染的风险。
